Serina Therapeutics Inc (SER)

Serina Therapeutics Revenue

In the year 2023, Serina Therapeutics had annual revenue of $142.00K with 317.65% growth. Revenue in the quarter ending December 31, 2023 was $56.00K with 600.00% year-over-year growth.

• Revenue (ttm): $142.00K
• Revenue Growth: +317.65%
• P/S Ratio: 156.74
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 22.26M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	142.00K	108.00K	317.65%
Dec 31, 2022	34.00K	-110.00K	-76.39%
Dec 31, 2021	144.00K	-217.00K	-60.11%
Dec 31, 2020	361.00K	-1.37M	-79.11%
Dec 31, 2019	1.73M	332.00K	23.78%
Dec 31, 2018	1.40M	-8.00K	-0.57%
Dec 31, 2017	1.40M	-262.00K	-15.73%
Dec 31, 2016	1.67M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.